Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Mercy Regional Cancer Center at Mercy Hospital
mi
from
Port Huron, MI
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Mercy Regional Cancer Center at Mercy Hospital
mi
from
Port Huron, MI
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Seton Cancer Institute at Saint Mary's - Saginaw
mi
from
Saginaw, MI
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Seton Cancer Institute at Saint Mary's - Saginaw
mi
from
Saginaw, MI
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
Saint Joseph, MI
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
St. John Macomb Hospital
mi
from
Warren, MI
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
St. John Macomb Hospital
mi
from
Warren, MI
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Avera Cancer Institute
mi
from
Sioux Falls, SD
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated:  12/31/1969
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
A Survey of Disease and Treatment-Related Symptoms in Patients With Invasive Cancer: Prevalence, Severity and Treatment
Status: Enrolling
Updated: 12/31/1969
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
ED Recovery in Men Age
Erectile Dysfunction Recovery in Men Age Status: Enrolling
Updated:  12/31/1969
City of Hope
mi
from
Duarte, CA
ED Recovery in Men Age
Erectile Dysfunction Recovery in Men Age Status: Enrolling
Updated: 12/31/1969
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Water Versus Saline as Irrigation Fluid for Ureteroscopy
The Effects of Water Versus Saline on Absorption Rates and Visualization During Ureteroscopy
Status: Enrolling
Updated:  12/31/1969
Grady Health System
mi
from
Atlanta, GA
Water Versus Saline as Irrigation Fluid for Ureteroscopy
The Effects of Water Versus Saline on Absorption Rates and Visualization During Ureteroscopy
Status: Enrolling
Updated: 12/31/1969
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
Water Versus Saline as Irrigation Fluid for Ureteroscopy
The Effects of Water Versus Saline on Absorption Rates and Visualization During Ureteroscopy
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Water Versus Saline as Irrigation Fluid for Ureteroscopy
The Effects of Water Versus Saline on Absorption Rates and Visualization During Ureteroscopy
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
BN83495 in Prostate Cancer
A Phase I Dose Escalating Study Evaluating the Pharmacodynamic Profile and Safety of BN83495 in Patients With Prostate Cancer With Evidence of Disease Progression While on Androgen Ablative Therapy
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University Medical Center
mi
from
Baltimore, MD
BN83495 in Prostate Cancer
A Phase I Dose Escalating Study Evaluating the Pharmacodynamic Profile and Safety of BN83495 in Patients With Prostate Cancer With Evidence of Disease Progression While on Androgen Ablative Therapy
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
BN83495 in Prostate Cancer
A Phase I Dose Escalating Study Evaluating the Pharmacodynamic Profile and Safety of BN83495 in Patients With Prostate Cancer With Evidence of Disease Progression While on Androgen Ablative Therapy
Status: Enrolling
Updated:  12/31/1969
Duke University Medical Center United States
mi
from
Durham, NC
BN83495 in Prostate Cancer
A Phase I Dose Escalating Study Evaluating the Pharmacodynamic Profile and Safety of BN83495 in Patients With Prostate Cancer With Evidence of Disease Progression While on Androgen Ablative Therapy
Status: Enrolling
Updated: 12/31/1969
Duke University Medical Center United States
mi
from
Durham, NC
Click here to add this to my saved trials
BN83495 in Prostate Cancer
A Phase I Dose Escalating Study Evaluating the Pharmacodynamic Profile and Safety of BN83495 in Patients With Prostate Cancer With Evidence of Disease Progression While on Androgen Ablative Therapy
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
BN83495 in Prostate Cancer
A Phase I Dose Escalating Study Evaluating the Pharmacodynamic Profile and Safety of BN83495 in Patients With Prostate Cancer With Evidence of Disease Progression While on Androgen Ablative Therapy
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-Prostatectomy
Status: Enrolling
Updated:  12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-Prostatectomy
Status: Enrolling
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
A Randomized, Placebo-Controlled Trial Of Celecoxib In Men Pre-Prostatectomy For Clinically Localized Adenocarcinoma Of The Prostate: Evaluation Of Drug-Specific Biomarker Modulation
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
A Randomized, Placebo-Controlled Trial Of Celecoxib In Men Pre-Prostatectomy For Clinically Localized Adenocarcinoma Of The Prostate: Evaluation Of Drug-Specific Biomarker Modulation
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin in Men With Advanced Localized Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin in Men With Advanced Localized Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin in Men With Advanced Localized Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin in Men With Advanced Localized Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin in Men With Advanced Localized Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
A Pharmacodynamic Study of Pre-Prostatectomy Rapamycin in Men With Advanced Localized Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Mind-Body Health in Uro-Oncology: Research Study
Mind-Body Health in Uro-Oncology: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Mind-Body Health in Uro-Oncology: Research Study
Mind-Body Health in Uro-Oncology: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Mind-Body Health in Uro-Oncology: Research Study
Mind-Body Health in Uro-Oncology: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
NorthShore University HealthSystem
mi
from
Evanston, IL
Mind-Body Health in Uro-Oncology: Research Study
Mind-Body Health in Uro-Oncology: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate
MOSAIC-P: Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate
Status: Enrolling
Updated:  12/31/1969
NorthShore University HealthSystem
mi
from
Evanston, IL
Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate
MOSAIC-P: Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate
Status: Enrolling
Updated: 12/31/1969
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Urology Centers of Alabama
mi
from
Homewood, AL
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Urology Centers of Alabama
mi
from
Homewood, AL
Click here to add this to my saved trials
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Walter Reed Army Medical Center
mi
from
Washington,
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Lawrenceville Urology
mi
from
Lawrenceville, NJ
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Lawrenceville Urology
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Presbyterian Hospital Center for Cancer Research
mi
from
Charlotte, NC
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Presbyterian Hospital Center for Cancer Research
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Urology Associates
mi
from
Nashville, TN
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Urology Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Urology Clinics of North Texas
mi
from
Dallas, TX
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Urology Clinics of North Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Urology Associates of South Texas,PA
mi
from
McAllen, TX
A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
An Open-Label, Phase I Dose Escalation Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Urology Associates of South Texas,PA
mi
from
McAllen, TX
Click here to add this to my saved trials
Personal Web Page In Clinical Trial Participant Education
Use of a Video-based, Personalized Web Page as a Complement to Standard Patient Education for Clinical Trial Participants
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Personal Web Page In Clinical Trial Participant Education
Use of a Video-based, Personalized Web Page as a Complement to Standard Patient Education for Clinical Trial Participants
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).
DescriPtive Analysis of Real-world Clinical Outcomes of Second Line (2L) Novel Anti-HormonE Therapy (NAH) or RadIum-223 (Xofigo) in Patients With Metastatic Castration Resistance Prostate Cancer (mCRPC) After First Line (1L) NAH Therapy
Status: Enrolling
Updated:  12/31/1969
US Flatiron prostate cancer database
mi
from
Whippany, NJ
Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).
DescriPtive Analysis of Real-world Clinical Outcomes of Second Line (2L) Novel Anti-HormonE Therapy (NAH) or RadIum-223 (Xofigo) in Patients With Metastatic Castration Resistance Prostate Cancer (mCRPC) After First Line (1L) NAH Therapy
Status: Enrolling
Updated: 12/31/1969
US Flatiron prostate cancer database
mi
from
Whippany, NJ
Click here to add this to my saved trials
A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
A Randomized Phase 2 Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
A Randomized Phase 2 Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
A Randomized Phase 2 Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Augsburg,
A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer
A Randomized Phase 2 Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Augsburg,
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Charles White, MD
mi
from
Mobile, AL
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Charles White, MD
mi
from
Mobile, AL
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Douglas Young, MD
mi
from
Fair Oaks, CA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Douglas Young, MD
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Rodney Anderson, MD
mi
from
Stanford, CA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Rodney Anderson, MD
mi
from
Stanford, CA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Eugene Dula, MD
mi
from
Van Nuys, CA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Eugene Dula, MD
mi
from
Van Nuys, CA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Joel Kaufman, MD
mi
from
Aurora, CO
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Joel Kaufman, MD
mi
from
Aurora, CO
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Donald Bergner, MD
mi
from
Clearwater, FL
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Donald Bergner, MD
mi
from
Clearwater, FL
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Ira Klimberg, MD
mi
from
Ocala, FL
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Ira Klimberg, MD
mi
from
Ocala, FL
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Gary Friedlander, MD
mi
from
Rockville, MD
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Gary Friedlander, MD
mi
from
Rockville, MD
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Sheldon Freedman, MD
mi
from
Las Vegas, NV
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Sheldon Freedman, MD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Edward Loizides, MD
mi
from
Bay Shore, NY
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Edward Loizides, MD
mi
from
Bay Shore, NY
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Richard Landau, MD
mi
from
Sellersville, PA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Richard Landau, MD
mi
from
Sellersville, PA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
H. Pat Hezmall, MD
mi
from
Fort Worth, TX
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
H. Pat Hezmall, MD
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Michael Godschalk, MD
mi
from
Richmond, VA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Michael Godschalk, MD
mi
from
Richmond, VA
Click here to add this to my saved trials
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  6/23/2005
Roger Fincher, MD
mi
from
Spokane, WA
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 6/23/2005
Roger Fincher, MD
mi
from
Spokane, WA
Click here to add this to my saved trials
Gene Therapy for Prostate Cancer That Returns After Radiation Therapy
Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients With Radiorecurrent Prostate Cancer
Status: Enrolling
Updated:  6/23/2005
Mount Sinai School of Medicine
mi
from
New York, NY
Gene Therapy for Prostate Cancer That Returns After Radiation Therapy
Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients With Radiorecurrent Prostate Cancer
Status: Enrolling
Updated: 6/23/2005
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy
Status: Enrolling
Updated:  9/12/2005
New York Prostate Institute
mi
from
Oceanside, NY
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy
Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy
Status: Enrolling
Updated: 9/12/2005
New York Prostate Institute
mi
from
Oceanside, NY
Click here to add this to my saved trials
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
Status: Enrolling
Updated:  9/20/2005
Department Of Veterans Affairs NJ Health Care System
mi
from
East Orange, NJ
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
Status: Enrolling
Updated: 9/20/2005
Department Of Veterans Affairs NJ Health Care System
mi
from
East Orange, NJ
Click here to add this to my saved trials